Broderick Brian C Trims Stock Holdings in Cigna Group $CI

Broderick Brian C reduced its position in Cigna Group (NYSE:CI) by 10.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 851 shares of the health services provider’s stock after selling 100 shares during the quarter. Broderick Brian C’s holdings in Cigna Group were worth $281,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Flaharty Asset Management LLC purchased a new position in Cigna Group during the 1st quarter worth $28,000. 1248 Management LLC acquired a new stake in shares of Cigna Group during the first quarter worth about $29,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares during the last quarter. Retirement Wealth Solutions LLC increased its position in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 43 shares during the period. Finally, Saudi Central Bank purchased a new stake in Cigna Group during the 1st quarter valued at approximately $36,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent research reports. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. TD Cowen upgraded shares of Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Royal Bank Of Canada reissued an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research note on Saturday, September 27th. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a research note on Tuesday, August 5th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $372.69.

Insider Buying and Selling

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $307.21 on Wednesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $358.88. The firm has a market capitalization of $82.00 billion, a P/E ratio of 16.77, a PEG ratio of 0.89 and a beta of 0.45. The company’s fifty day moving average is $292.94 and its two-hundred day moving average is $309.54.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.